GC Aesthetics and Bimini Health Tech Form Strategic Partnership to Advance Breast Reconstruction Solutions Globally
This strategic collaboration combines GC Aesthetics‘ 40 years’ experience in design, manufacturing, and distribution of Silicone Breast Implants with Bimini’s expertise in Breast Reconstruction innovation. The result: an unprecedented commitment to providing women with best-in-class solutions for breast reconstruction across the globe, including the USA, LATAM, EMEA, and APAC.
Under the umbrella of the Joint Venture named “OPALINE Aesthetics”, GC Aesthetics will deploy Bimini’s healthcare solutions outside the United States and Canada. Conversely, Bimini will commercialize selective GC Aesthetics’ breast reconstruction solutions into the United States which will complement its industry leading Puregraft portfolio of technologies that offer a broad set of solutions to plastic and reconstructive surgeons.
“We want to provide patients around the globe, state-of-the-art breast reconstruction solutions with a demonstrated best in class safety profile”, said Carlos Reis Pinto, CEO of GC Aesthetics. “The combination of Bimini and GCA portfolios will not only expand patient access to broader solutions but it will also lead to the development of new technologies which will improve the standard of care in Breast Reconstruction”, said Brad Conlan, CEO and co-founder of Bimini Health Tech.
The driving force behind this partnership is a shared commitment to patients and plastic surgeons. By joining forces, GC Aesthetics and Bimini Health Tech aim to elevate women's healthcare and well-being, offering comprehensive support for breast reconstruction needs.
Breast Reconstruction requires dedication and commitment to Women Healthcare. Collectively we will embark on this journey to contribute to women's Health and well-being, partnering with medical professionals around the world.
About GC Aesthetics
GC Aesthetics is a long-established global medical technology company that develops, manufactures, and markets a comprehensive range of proprietary aesthetic and reconstructive products. Throughout its 40-year history, GCA has been dedicated to advancing the science of medical aesthetics and delivering high-quality breast implants for breast augmentation and breast reconstructive surgery. We have sold more than 3 million implants across 70 countries, and our products are supported by published 10-year clinical data.
Learn more at www.gcaesthetics.com
About Bimini Health Tech:
Founded in 2013, Bimini Health Tech is a global leader in the regenerative, aesthetic, plastic and reconstructive surgery sectors. Backed by decades of experience, Bimini is committed to the development, acquisition, and commercialization of innovative products that provide premium solutions for patients and physicians. Our portfolio includes the brands Puregraft® (Adipose Filtration System, Serene Breast Implant, Essence Acellular Dermal Matrix), Healeon®, Dermapose®, and Kerastem®. Supported by over a 100 patents, 20 device clearances and approvals, and over 25 scientific publications, Bimini’s products have been utilized in over 1.5 million procedures worldwide.
Learn more at www.biminihealthtech.com
View source version on businesswire.com: https://www.businesswire.com/news/home/20231026545758/en/
Website: https://www.gcaesthetics.com/
View Korean version of this release
Contact
GC Aesthetics
Carlos Reis Pinto
carlosreispinto@gcaesthetics.com
This news is a press release provided by GC Aesthetics. Korea Newswire follows these editorial guidelines.
-
1월 28일 10:30